Related references
Note: Only part of the references are listed.Learning from berberine: Treating chronic diseases through multiple targets
Yao Jing et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
The effect of gut microbiota on drug metabolism
Mi Jeong Kang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Excretion of Berberine and Its Metabolites in Oral Administration in Rats
Jing-Yi Ma et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
W. H. Wilson Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats
Xiang-Shan Tan et al.
PLOS ONE (2013)
Synthesis and structure-activity relationship of berberine analogues in LDLR up-regulation and AMPK activation
Yan-Xiang Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials (Publication with Expression of Concern. See vol. 13, pg. 177, 2018)
Giuseppe Derosa et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Identification of metabolites of FR429, a potential antitumor ellagitannin, transformed by rat intestinal bacteria in vitro, based on liquid chromatography-ion trap-time of flight mass spectrometry analysis
Jie Fu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2012)
Functional interactions between the gut microbiota and host metabolism
Valentina Tremaroli et al.
NATURE (2012)
Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats
Xu Zhang et al.
PLOS ONE (2012)
Effects and mechanisms of berberine in diabetes treatment
Jun Yin et al.
ACTA PHARMACEUTICA SINICA B (2012)
Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats
Wei Chen et al.
AAPS PHARMSCITECH (2011)
Gut microbiome, obesity, and metabolic dysfunction
Herbert Tilg et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice
Weidong Xie et al.
PLOS ONE (2011)
Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders
Giovanni Musso et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
Hao Zhang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor
Yan-Xiang Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota
Patrice D. Cani et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Hepatocyte Nuclear Factor 1α Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
Hai Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Berberine Analogues as a Novel Class of the Low-Density-Lipoprotein Receptor Up-Regulators: Synthesis, Structure-Activity Relationships, and Cholesterol-Lowering Efficacy
Ying-Hong Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis and structure-activity relationships of berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators
Peng Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-Activated protein kinase and improve insulin action
Nigel Turner et al.
DIABETES (2008)
The gastrointestinal microbiota as a site for the biotransformation of drugs
Tiago Sousa et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Reduction of polynitroaromatic compounds: the bacterial nitroreductases
Maria Dolores Roldan et al.
FEMS MICROBIOLOGY REVIEWS (2008)
Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
Ina Hubatsch et al.
NATURE PROTOCOLS (2007)
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
Yun S. Lee et al.
DIABETES (2006)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
Flavin thermodynamics explain the oxygen insensitivity of enteric nitroreductases
RL Koder et al.
BIOCHEMISTRY (2002)
The involvement of P-glycoprotein in berberine absorption
GY Pan et al.
PHARMACOLOGY & TOXICOLOGY (2002)
Share Paper
